Collaboration and competition: ethics in toxicology

Area of Science:

• Pharmaceutical Toxicology
• Bioethics
• Drug Development

Background:

• Toxicology is crucial in drug development, facing evolving societal and scientific concerns.
• Key ethical challenges include animal testing and high safety-related attrition rates in new drug development.
• Current research funding disproportionately favors efficacy models over essential ethical and safety research.

Purpose of the Study:

• To explore current toxicological paradigms with potential ethical ramifications.
• To identify underpinnings of these practices and propose actionable recommendations.
• To enhance the ethical standing and relevance of pharmaceutical toxicology.

Main Methods:

• Analysis of current practices in pharmaceutical toxicology.
• Review of ethical challenges in animal testing and drug attrition.
• Exploration of funding allocation in toxicological research.
• Discussion of principles from the 2004 Paton Prize lecture on ethical behavior.

Main Results:

• Significant underinvestment in critical areas of toxicological research, such as animal welfare and attrition reduction.
• Identification of potential ethical conflicts stemming from current toxicological practices.
• Lack of adequate resources and transparency hinders progress in ethical toxicology.

Conclusions:

• Urgent need for increased research funding in pharmaceutical toxicology, focusing on ethical considerations.
• Recommendations for enhancing ethical practices include improving peer review, resourcing, transparency, and data sharing.
• Addressing these issues is vital for maintaining toxicology's relevance and societal trust.